Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker

H.Res. 1285 · Where this bill is now

In committee

Introduced in the House, sent to the Committee on Energy and Commerce, May 14, 2026

119th Congress
2nd SessionH.Res. 1285

RESOLUTION

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

In the HouseNo vote yet

Sponsor: Rep. Diana DeGette (D-CO-1) · Introduced May 14, 2026 · Health · 1 version of the text

Read the full billOfficial record on Congress.gov ↗

Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action May 14, 2026: “Referred to the House Committee on Energy and Commerce.”

Sections

Sections · 1
H.Res. 1285: Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. — Bill Status, Votes and Text · Public Law Tracker